Legal & General Group Plc purchased a new stake in shares of Kenvue Inc. (NYSE:KVUE – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 13,259,718 shares of the company’s stock, valued at approximately $253,393,000. Legal & General Group Plc owned approximately 0.69% of Kenvue as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of KVUE. Elyxium Wealth LLC acquired a new position in Kenvue during the 4th quarter worth approximately $26,000. Johnson Financial Group Inc. purchased a new stake in shares of Kenvue during the second quarter valued at approximately $26,000. MV Capital Management Inc. purchased a new stake in shares of Kenvue during the fourth quarter valued at approximately $28,000. CoreCap Advisors LLC lifted its position in shares of Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock worth $29,000 after purchasing an additional 591 shares in the last quarter. Finally, Reflection Asset Management purchased a new position in shares of Kenvue in the fourth quarter valued at $32,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Kenvue Stock Performance
Shares of KVUE stock opened at $19.23 on Thursday. The company has a market cap of $36.94 billion, a P/E ratio of 22.10, a PEG ratio of 1.38 and a beta of 0.47. The business has a 50 day moving average of $19.12 and a two-hundred day moving average of $18.23. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $20.95. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67.
Kenvue Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were issued a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date of this dividend was Wednesday, August 12th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio is currently 96.55%.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on KVUE shares. Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Wall Street Zen cut shares of Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Barclays upped their price objective on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Finally, UBS Group cut their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Three investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $19.27.
Check Out Our Latest Research Report on Kenvue
Kenvue Profile
Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.
The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.
Featured Stories
- Five stocks we like better than Kenvue
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
